A detailed history of Td Asset Management Inc transactions in Boston Scientific Corp stock. As of the latest transaction made, Td Asset Management Inc holds 2,152,974 shares of BSX stock, worth $183 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
2,152,974
Previous 2,059,261 4.55%
Holding current value
$183 Million
Previous $141 Million 17.56%
% of portfolio
0.16%
Previous 0.14%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

BUY
$67.33 - $77.71 $6.31 Million - $7.28 Million
93,713 Added 4.55%
2,152,974 $166 Million
Q1 2024

May 08, 2024

BUY
$57.6 - $68.62 $25.5 Million - $30.4 Million
443,329 Added 27.43%
2,059,261 $141 Million
Q4 2023

Feb 12, 2024

BUY
$48.64 - $57.81 $7.57 Million - $8.99 Million
155,565 Added 10.65%
1,615,932 $93.4 Million
Q3 2023

Oct 27, 2023

BUY
$50.19 - $54.68 $16 Million - $17.4 Million
318,058 Added 27.84%
1,460,367 $77.1 Million
Q2 2023

Aug 09, 2023

BUY
$49.72 - $54.64 $9.61 Million - $10.6 Million
193,329 Added 20.37%
1,142,309 $61.8 Million
Q1 2023

May 10, 2023

BUY
$45.09 - $50.03 $10.7 Million - $11.8 Million
236,286 Added 33.15%
948,980 $47.5 Million
Q4 2022

Feb 06, 2023

BUY
$39.56 - $47.22 $5.75 Million - $6.86 Million
145,321 Added 25.61%
712,694 $33 Million
Q3 2022

Nov 07, 2022

BUY
$36.71 - $109.66 $431,012 - $1.29 Million
11,741 Added 2.11%
567,373 $22.3 Million
Q2 2022

Aug 04, 2022

BUY
$35.24 - $47.1 $6,977 - $9,325
198 Added 0.04%
555,632 $20.7 Million
Q1 2022

May 10, 2022

BUY
$40.9 - $45.1 $105,358 - $116,177
2,576 Added 0.47%
555,434 $24.6 Million
Q4 2021

Feb 10, 2022

BUY
$38.07 - $44.87 $443,249 - $522,421
11,643 Added 2.15%
552,858 $23.5 Million
Q3 2021

Nov 09, 2021

SELL
$41.23 - $45.88 $257,192 - $286,199
-6,238 Reduced 1.14%
541,215 $23.5 Million
Q2 2021

Aug 11, 2021

BUY
$38.58 - $44.24 $904,392 - $1.04 Million
23,442 Added 4.47%
547,453 $25 Million
Q1 2021

May 14, 2021

SELL
$35.27 - $39.67 $26,205 - $29,474
-743 Reduced 0.14%
524,011 $20.3 Million
Q4 2020

Feb 16, 2021

SELL
$33.15 - $41.97 $28.5 Million - $36.1 Million
-859,766 Reduced 62.1%
524,754 $18.9 Million
Q3 2020

Nov 10, 2020

SELL
$34.44 - $42.23 $18.1 Million - $22.1 Million
-524,152 Reduced 27.46%
1,384,520 $52.9 Million
Q2 2020

Aug 13, 2020

SELL
$30.19 - $39.11 $7.07 Million - $9.16 Million
-234,103 Reduced 10.93%
1,908,672 $67 Million
Q1 2020

May 15, 2020

SELL
$25.83 - $45.71 $8.47 Million - $15 Million
-327,903 Reduced 13.27%
2,142,775 $69.9 Million
Q4 2019

Feb 11, 2020

SELL
$37.87 - $45.37 $15.3 Million - $18.3 Million
-404,065 Reduced 14.06%
2,470,678 $112 Million
Q3 2019

Nov 07, 2019

SELL
$40.31 - $43.45 $32.2 Million - $34.7 Million
-798,996 Reduced 21.75%
2,874,743 $117 Million
Q2 2019

Aug 01, 2019

SELL
$34.91 - $42.98 $2.16 Million - $2.66 Million
-61,919 Reduced 1.66%
3,673,739 $158 Million
Q1 2019

May 08, 2019

BUY
$32.91 - $40.75 $4.9 Million - $6.07 Million
148,884 Added 4.15%
3,735,658 $143 Million
Q4 2018

Feb 01, 2019

SELL
$31.73 - $39.04 $2.01 Million - $2.48 Million
-63,476 Reduced 1.74%
3,586,774 $127 Million
Q3 2018

Nov 01, 2018

BUY
$32.83 - $38.63 $38.1 Million - $44.9 Million
1,161,994 Added 46.7%
3,650,250 $141 Million
Q2 2018

Jul 31, 2018

BUY
$26.84 - $34.32 $56.2 Million - $71.9 Million
2,094,436 Added 531.83%
2,488,256 $81.4 Million
Q1 2018

May 11, 2018

SELL
$25.2 - $28.54 $522,169 - $591,377
-20,721 Reduced 5.0%
393,820 $10.8 Million
Q4 2017

Feb 02, 2018

SELL
$24.79 - $29.8 $369,891 - $444,645
-14,921 Reduced 3.47%
414,541 $10.3 Million
Q3 2017

Nov 09, 2017

BUY
$26.26 - $29.17 $11.3 Million - $12.5 Million
429,462
429,462 $12.5 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $121B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.